About this Research Topic
In the field of infectious diseases, antibiotic resistance in gastrointestinal infections represents a critical challenge. Such infections, driven by pathogens like Salmonella, Escherichia coli, and Campylobacter, not only cause severe illnesses but also contribute significantly to morbidity due to their resistance to standard treatments. The evolution of antibiotic-resistant bacteria is exacerbated by the indiscriminate use of antibiotics in healthcare and agriculture, hindering effective treatment regimens and facilitating the spread of resistant strains via multiple vectors including contaminated food and water.
This research topic aims to delve into the complexities of diagnosing antibiotic-resistant infections with precision, and to spearhead the creation of innovative management tools. It seeks to scrutinize the efficacy of existing diagnostic practices and develop novel methodologies for the timely detection and monitoring of such infections. Furthermore, the research intends to investigate groundbreaking strategies for treating antibiotic-resistant infections, including the synthesis of new antimicrobial agents, the application of stringent infection control protocols, and leveraging computational models to uncover novel therapeutic candidates.
To gather further insights into the mechanisms and treatment of antibiotic-resistant gastrointestinal infections, we welcome articles addressing, but not limited to, the following themes:
-Research on isolation, identification, and characterization of strains causing gastrointestinal diseases with a multiresistant profile.
-Identification and characterization of mechanisms of resistance.
-No-drugs alternatives for the treatment of multiresistant infections (i.e., probiotics, natural compounds, bacteriophages).
-In silico discovery of new antimicrobial drugs.
-Pangenome characterization of multiresistant organisms.
-Multiresistant organisms from both animals and humans.
This research topic aims to delve into the complexities of diagnosing antibiotic-resistant infections with precision, and to spearhead the creation of innovative management tools. It seeks to scrutinize the efficacy of existing diagnostic practices and develop novel methodologies for the timely detection and monitoring of such infections. Furthermore, the research intends to investigate groundbreaking strategies for treating antibiotic-resistant infections, including the synthesis of new antimicrobial agents, the application of stringent infection control protocols, and leveraging computational models to uncover novel therapeutic candidates.
To gather further insights into the mechanisms and treatment of antibiotic-resistant gastrointestinal infections, we welcome articles addressing, but not limited to, the following themes:
-Research on isolation, identification, and characterization of strains causing gastrointestinal diseases with a multiresistant profile.
-Identification and characterization of mechanisms of resistance.
-No-drugs alternatives for the treatment of multiresistant infections (i.e., probiotics, natural compounds, bacteriophages).
-In silico discovery of new antimicrobial drugs.
-Pangenome characterization of multiresistant organisms.
-Multiresistant organisms from both animals and humans.
Keywords: Gastrointestinal infections, Multidrug resistant bacteria, Antibiotics, in silico, Human gastrointestinal infections, Animal gastrointestinal infections
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
